Analyst Ratings for Entera Bio (ENTX)
ENTX Rating Summary
ENTX Price Target Summary
- Highest: $11.00 (Guggenheim)
- Lowest: $9.00 (H.C. Wainwright)
- Average: $9.67
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$9.67 (+210.8%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$9.67 (+210.8%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/25/2026 | Guggenheim | Vamil Divan | New Coverage | Buy (N/A) |
11.00 (N/A) |
2.81 (3.11) |
10.68% | Details |
| 9/22/2026 | Cantor Fitzgerald | Imogen Mansfield | New Coverage | Overweight (N/A) |
N/A (N/A) |
2.96 (3.11) |
5.07% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
